Viewing Study NCT00461851


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:53 PM
Study NCT ID: NCT00461851
Status: COMPLETED
Last Update Posted: 2017-12-14
First Post: 2007-04-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
Sponsor: Yale University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-03
Start Date Type: None
Primary Completion Date: 2013-08
Primary Completion Date Type: ACTUAL
Completion Date: 2013-08
Completion Date Type: ACTUAL
First Submit Date: 2007-04-16
First Submit QC Date: None
Study First Post Date: 2007-04-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-09-12
Results First Submit QC Date: None
Results First Post Date: 2016-11-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-11-15
Last Update Post Date: 2017-12-14
Last Update Post Date Type: ACTUAL